NCT00444106View on ClinicalTrials.gov

Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function

PHASE4CompletedINTERVENTIONAL

Enrollment

265

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

MalariaFalciparum

Interventions

DRUG

Artesunate-mefloquine

DRUG

Atovaquone-proguanil

DRUG

Artemether-lumefantrine

Trial Locations (1)

Unknown

Novartis Investigational Site, Tumaco

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY

NCT00444106 - Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function | Biotech Hunter | Biotech Hunter